Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2017-11-01 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75011), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LV : revenue, balance sheet and financial ratios
PHARMACIE LV is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75011),
this company of category PME
shows in 2022 a net income positive of 316 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LV (SIREN 832907489)
Indicator
2022
2018
Revenue
N/C
N/C
Net income
315 717 €
100 545 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2022, PHARMACIE LV generates positive net income of 316 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2022: 101 k€ -> 316 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
315 717 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 90%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
90.351%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.486%
Solvency indicators evolution PHARMACIE LV
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2022
Debt ratio
1290.694
90.351
Financial autonomy
6.403
48.486
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
90.352022
2018
2022
Q1: 24.52
Med: 74.72
Q3: 182.51
Average-21 pts over 2 years
In 2022, the debt ratio of PHARMACIE LV (90.35) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.49%2022
2018
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.61%
Good+27 pts over 2 years
In 2022, the financial autonomy of PHARMACIE LV (48.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE LV in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of PHARMACIE LV is estimated at
3 714 886 €
(range 2 497 142€ - 5 571 640€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
2497k€3714k€5571k€
3 714 886 €Range: 2 497 142€ - 5 571 640€
NAF 5 année 2022
Valuation method used
Net Income Multiple
315 717 €
×
11.8x
=3 714 887 €
Range: 2 497 142€ - 5 571 640€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LV with other companies in the same sector:
The revenue of PHARMACIE LV is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE LV profitable?
Yes, PHARMACIE LV generated a net profit of 316 k€ in 2022.
Where is the headquarters of PHARMACIE LV ?
The headquarters of PHARMACIE LV is located in PARIS (75011), in the department Paris.
Where to find the tax return of PHARMACIE LV ?
The tax return of PHARMACIE LV is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LV operate?
PHARMACIE LV operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart